Section 3:
Diagnosis, Treatment, and Research |
Diagnosis and Treatment
Your medical team will advise you on the best
diagnostic tests to use, and the best course of treatment for
the VHL involvement shown by your screening. There are a number
of very effective treatments, and more are being discovered.
In addition to physical examination by your doctor,
screening will probably involve some combination of magnetic
resonance imaging (MRI), computed tomography (CT) scanning,
ultrasound scanning, and angiography. The objective is to provide
diagnostic pictures of both the blood vessels and soft tissues
of your body. This may involve injecting contrast materials,
or dyes, into your bloodstream to help the doctors see the blood
vessels more clearly in the pictures. Various techniques are
also used to determine the density of the tissues being examined,
which helps the medical team determine whether it is normal
tissue, cyst, or tumor.
Positron Emission Tomography
(PET) scanning may be used to determine the activity level
of certain kinds of tumors.
Treatments usually involve some kind of surgery
to remove potentially malignant tumors before they become harmful
to other tissues. Evaluation of a surgical alternative is always
a matter of choosing the lesser of two evils. Surgery always
has some level of risk, but keeping the angioma or tumor also
has its risks. Advances are providing surgical alternatives
that are less invasive. You should discuss the relative risks
with your medical team.
Even the list of risks that the anesthesiologist
reads off before surgery can sound frightening. It is sometimes
helpful to say to the doctor, “What odds would you give
me of one of those things happening?” Finding out that
they are reading a list of things, all of which add up to less
than 4%, as opposed to a risk level of 50%, helps to put the
risk into perspective. Each of us must examine the relative
benefits and risks of a proposed surgery in consultation with
our medical teams.
Genetic Research and VHL
DNA (deoxyribonucleic acid) is the biochemical
basis of life and of heredity. All of an individual’s
characteristics are written in DNA in a kind of code. DNA is
assembled into microscopic structures called chromosomes. In
the human species there are 46 chromosomes,
23 from the mother and 23 from the father. There are 22 autosomes,
numbered 1 to 22, of which each person has a pair (two copies
of chromosome 1, two of chromosome 2, etc...) and one pair of
the “sex” chromosomes, XX for females and XY for
males. On each chromosome are the genes that contain the specific
information necessary for the manufacture of proteins. Each
gene has two copies, one inherited from the father, and one
from the mother. The condition called VHL is caused by a dominant
gene, since only one faulty copy of the VHL gene will cause
the condition. VHL occurs in both men and women. Each child
of a person with VHL is at 50% risk of inheriting the faulty
copy of the gene.
The VHL gene is located on the short arm of chromosome
3 at a site called 3p25-p26 (see Figure 10). An international
team of scientists identified the precise structure of this
gene in 1993. Alterations in the normal structure of this gene
are known to result in the condition called VHL.

Figure 10: VHL gene location.
The VHL gene is in the region 3p25-p26, near
the tip of the short arm of chromosome 3. Illustration
by Karen Barnes, Stansbury Ronsaville Wood, Inc., for
Howard Hughes Medical Institute, as published in Blazing
a Genetic Trail, 1991. |
The VHL gene encodes the formula for a protein
whose function seems extremely important in the fundamental
process called “transcription” which permits DNA
to be transformed into a more simple molecule, RNA, which is
used to create the protein.
The normal VHL gene acts as a “tumor-suppressor
gene,” whose normal function is to suppress the formation
of tumors. In order for a tumor to form, both copies of the
VHL gene (the one from the father and the one from the mother)
must become inactivated. In an individual who does not have
the inherited alteration in the VHL gene, it is necessary for
each of these two normal copies of the VHL gene to undergo some
change that inactivates the VHL protein and allows a tumor to
form. This may take some time, and multiple damaging “hits”
to the genes in this cell, before the tumor will form. This
explains why when these tumors occur in the general population
they are usually single occurrences in a single organ, and the
average age of onset of symptomatic kidney cancer in the general
population is age 62. Mutation or inactivation of the VHL gene
has been found in 85% of the random kidney cancers in the general
population studied by the U.S. National Cancer Institute (Duan,
1995). This demonstrates the importance of this gene and the
protein it manufactures in every human being.
In the case of people who have inherited one
copy of the gene that doesn’t work correctly in the beginning,
it is only necessary to deactivate the one remaining copy before
a tumor may form. This is a much more likely occurrence, which
means that tumors develop more often, at younger ages, and in
more organs than in people in the general population. Without
preventive action, the average age of onset of symptomatic kidney
cancer in people with VHL is age 42. (See Figure 11).

Figure 11: Path to development
of a tumor. The VHL gene acts as a tumor suppressor
gene. For a tumor to develop, both copies of the VHL
gene (the one inherited from the father and the one
inherited from the mother) must both become altered
or otherwise inactivated. In people with VHL, one of
these copies is already inactive, and only one additional
step is required for a tumor to start. Illustration
from S. Richard and the French VHL Study Group. |
These alterations (or “mutations”)
of the VHL gene can now be identified in most people with VHL.
The alteration is always the same in members of a single family.
Conversely, the precise alteration in the gene will be different
from one VHL family to another. More than 500 individual mutations
have already been described in the medical literature (Béroud,
Worldwide VHL Mutations Database). There is a significant relationship
between certain kinds of mutations and the likelihood of pheochromocytomas.
Researchers are studying other specific mutations which may
be responsible for different aspects of VHL.
In most cases, the alteration in the VHL gene
occurred a very long time ago, and the original mutation has
been passed down through several generations in a family. VHL
in the Black Forest Family in Germany and Pennsylvania has been
documented back to the early 1600’s. There are certain
people, though, perhaps as many as 20%, who are the first in
their family to have an alteration in the VHL gene. Neither
parent is affected, and these people have a case of VHL, occurring
“de novo,” for
the first time. This “new mutation” is caused by
a change in the gene in one sperm from the father, or in one
egg from the mother, or in the copying of the gene in one of
the first stages of division of the embryo. This alteration
in the VHL gene can now be passed to future children of this
affected person, and necessitates medical screening of these
children as well. There are no reliable statistics yet on the
rate of new VHL mutations. Currently about 20% of patients are
new mutations, and more “de novo” cases of VHL are
being identified as awareness of VHL increases.
Progress toward a Cure
It is now possible to do special tests called
DNA tests in most families to determine who is and is not at
risk. If you don’t have the altered VHL gene, you cannot
pass it to your children, and you need not go through further
VHL screening tests. Identifying people who are not at risk
allows those people to be reassured and spared further worry
and testing. DNA testing methods are becoming less expensive
and can now find the VHL gene alteration in most families. (See
Section 6, Obtaining DNA Testing.)
With the gene identified, there is also increased
hope of a cure, or at least of better management for VHL. Already
in 2005 we have made great strides in improving diagnosis and
treatment of VHL.
We have been working with the scientists and the
pharmaceutical companies to come up with a drug that will constrain
tumor growth.
"The identification of tumor suppressor
genes whose loss of function results in
predisposition to cancer has taken center stage in our
attempts to understand human carcinogenesis."
-- Dr. Richard Klausner, Chief, U.S. National Cancer
Institute, 1995 |
If VHL tumors can be kept small or made smaller,
we should be able to minimize the amount of surgical intervention
required to manage VHL. Meanwhile, though, our best defenses
are “early detection and appropriate treatment.”
In the near term, this booklet and partnership with your healthcare
team will be your best defense.
Remember that the vast improvements in the survivability
of prostate and breast cancer have been made without a curing
drug — the most important advances have been in early
detection and better treatment. The same can be said for VHL.
New research also shows that the VHL gene plays
a role in a signaling system that tells the cell how much oxygen
is available to it. When the VHL protein is missing, the cell
believes — even if it isn’t true — that it
is starving for oxygen. So it puts out distress signals to the
body, “Help! I need more oxygen!” The body responds
by building more blood vessels to bring more blood to bring
more oxygen. Thus VHL tumors seem to be a normal self-protective
response gone wrong. As we understand the function of the normal
VHL protein, we have a better chance of finding a drug that
will replace its function and keep tumors from growing.
As part of its function, the VHL protein combines
with other proteins in the cell (see Figures 12 and 13). Depending
where the genetic alteration occurs, its ability to form connections
with these other proteins may be impaired. We are beginning
to interpret these differences by studying the relationship
between the genotype (the place where the alteration occurs
in the gene) and the phenotype (the set of symptoms experienced
by these individuals). Researchers have identified four categories
of VHL, which may be useful in predicting the relative risk
in a family for certain manifestations of VHL. These categories
are not absolute; we still recommend screening for all the features
of VHL, though the frequency of testing might be varied depending
on the results of DNA testing. (See Figure 14).

Figure 12: The VHL Complex. The
VHL protein (pVHL) combines with Elongins B and C and
CUL2 to form a “complex”, a kind of sub-assembly,
which works as a machine to connect to other proteins
in the cell and mark them for degradation and elimination
-- a kind of clean-up machine or “off” switch
to stop processes from continuing. In this way it helps
to control the levels of at least 17 other proteins in
the cell. When this “off” function does not
work properly, certain compounds are in over-supply and
the process of cell growth and duplication goes out of
control, resulting in a tumor or other malfunction. The
alpha and beta domains marked are essentially connectors
along pVHL that latch onto these other compounds. If the
VHL mutation is in one of these connectors, the connector
doesn’t bind properly. Source: U.S. National
Cancer Institute, Science, 269:1995, PNAS, 94:1997. |
Researchers still have much laboratory work to
do to understand more about what the normal VHL protein does
in the body, and what happens when it is defective or absent.
Perhaps some day it will be possible to replace it chemically.
Some experimental methods in the areas of gene therapy or stem
cell therapy may permit replacement or correction of the genetic
information. These technologies are still in their infancy.
 |
Figure 13: Pathways in the cell.
If the pVHL complex is not functioning properly,
then the levels of Hypoxia Inducible Factor (HIF) rise,
which in turns allows the overproduction of Vascular Endothelial
Growth Factor (VEGF) and Platelet-derived Growth Factor
(PDGF) and others. These proteins send out signals to the
target cell to stimultate the growth and reproduction of
the cell. The signals are received by corresponding “receptors”
(like VEGFR and PDGFR in this picture). In order to stop
the signal from getting through, drugs may attempt to halt
the signal, trap it in transit, or block the receptor.
Source: W. G. Kaelin Jr., Dana-Farber Cancer Research Institute.
Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6290S-5S. |
You and your family can help to move the progress
of VHL research forward by contributing samples of blood and
tumor tissue to any local research projects you can.
For example, there are a number of efforts to
identify biomarkers. These markers, found in blood or urine,
would indicate the level of tumor activity in the body without
expensive scans. In order to find such biomarkers, they need
samples of blood and urine from a large number of people with
VHL. Please help whenever you can.
When surgery is planned, call the VHL Tissue Bank
and register to donate the tissue your surgeon will be removing.
The Bank will arrange for tissue collection with your surgeon.
Remember that tissue not recovered within 24 hours cannot be
used for research. (See Section
10, Tissue Bank, for the donor registration form.)
When clinical trials are announced, please read
the announcement to determine whether the drug offered might
be appropriate to your particular circumstances. Please consider
participating in trials when they are right for you. Your top
priority should always be to do what is best for your present
and long-term health.
News of the current state of genetic research
on VHL is carried in the VHL Family Forum.
The VHL Family Alliance works to encourage research
on von Hippel-Lindau through the Research Database, the VHL
Tissue Bank, the VHL Fund for Cancer Research, and the VHLFA
Research Grants program.
(See Membership Information.) Please help to sustain these
efforts.
| Figure 14: Genotype-phenotype
classifications in families with von Hippel-Lindau
disease*. Source: Lancet 2003; 361: 2062. |
| |
Clinical Characteristics |
| Type 1 |
Retinal hemangioblastomas
CNS hemangioblastomas
Renal cell carcinoma
Pancreatic tumors and cysts |
| Type 2A |
Pheochromocytomas
Retinal hemangioblastomas
CNS hemangioblastomas |
| Type 2B |
Pheochromocytomas
Retinal hemangioblastomas
CNS hemangioblastomas
Renal cell carcinomas
Pancreatic tumors and cysts |
| Type 2C |
Pheochromocytoma only |
| *Endolymphatic sac tumors and
cystadenomas of the epididymis and broad ligament have not
been assigned to specific von Hippel-Lindau types. |
Section 4: Living
well with VHL |
There is no magic pill — yet! — that will make
VHL go away. VHL is a lifelong challenge. It is less demanding
of your attention than something like diabetes — you don’t
have to check your blood sugar multiple times a day or change
every aspect of your diet — but you do need to put the
right level of attention onto monitoring it, keeping your mind,
body, and spirit strong, and keeping this issue in perspective
in the whole of your life.
It is important to take care of your general level of health.
If you make sure that you are in good health, then the challenges
VHL throws your way will be easier to deal with. Eat right,
don’t smoke, exercise, drive carefully, and don’t
hide behind alcohol or drugs. Eat less red meat, and eat a diet
based more on vegetable sources (see Figure 15). Watch for cancer-prevention
tips in the press for ideas on how to keep your body’s
own natural defenses strong against the forces that cause cancer
by causing genes to become deactivated. This area is being closely
studied, and reliable information is only beginning to emerge.
One of the greatest known risk factors for any medical condition
is smoking. Studies on kidney tumors in the general population
indicate that patients who smoke, especially men, have more
tumors than those who don’t, and that those tumors grow
more rapidly. If you do need to have surgery, people who smoke
are at higher risk for a number of post-operative complications.
There is no evidence to indicate that VHL patients should limit
their physical activities in any way, except for short periods
following treatments. Certain kinds of brain, spinal, or eye
tumors, may be aggravated by doing a lot of heavy straining,
like bench-pressing 200 pound weights so that the veins in your
forehead stand out, pumping your exercising heart rate beyond
your recommended limits, or going through the hardest parts
of labor in childbirth. Check with your doctor to determine
your own exercise tolerance. Moderate exercise, however, is
good for everyone.
Some families with VHL are experimenting with cancer-prevention
diets and avoidance of growth hormone (fed to cattle and chickens
in some countries) in an attempt to soften the course of the
disease. Scientists are beginning to learn more about the ability
of some vegetables (notably fermented soy products and cruciferous
vegetables like cabbage) to retard the growth of new blood vessels.
Green tea may enhance the immune system. Genistein (an isoflavone
found in soy) has been shown to slow the growth of vascular
tumors of the eye.
If you are interested in adding this approach to your total
health plan, information is available from the VHL Family Alliance
or through the many cancer-prevention channels, including www.vhl.org/nutrition.
Ask at your medical center for recommendations on nutrition
for cancer prevention (See Figure 16).
 |
Figure 16: The Art
of Conscious Living
“When we are able to mobilize our inner resources
to face our problems artfully, we find we are usually
able to orient ourselves in such a way that we can use
the pressure of the problem itself to propel us through
it, just as a sailor can position a sail to make the best
use of the pressure of the wind to propel the boat. You
can’t sail straight into the wind, and if you only
know how to sail with the wind at your back, you will
only go where the wind blows you. But if you know how
to use the wind energy and are patient you can sometimes
get where you want to go. You can still be in control.
. .
We all accept that no one controls the
weather. Good sailors learn to read it carefully and respect
its power. They will avoid storms if possible, but when
caught in one, they know when to take down the sails,
batten down the hatches, drop anchor, and ride things
out, controlling what is controllable and letting go of
the rest. . . . Developing skill in facing and effectively
handling the various “weather conditions”
in your life is what we mean by the art of conscious living.”
— Jon Kabat-Zinn, Ph.D., Director
of the Stress Reduction Clinic at the University of Massachusetts
Medical Center, Worcester, Massachusetts. As quoted from
his book, Full Catastrophe Living: Using the Wisdom of
your Body and Mind to Face Stress, Pain and Illness, p.
3. (Delta Books, New York, 1990).
|
There is growing evidence that prolonged inflammation may have
some influence on the course of diseases such as cancer, Alzheimer’s
and heart disease. Dr. Weil recommends a diet rich in omega-3
fatty acids (walnuts, freshly ground flaxseed and oily fishes
are good sources). Extra-virgin olive oil is preferred over
sunflower, corn, and safflower oils. Use natural anti-inflammatory
spices like ginger and turmeric.
VHL is a chronic disease. While it may not affect your life
on a day-to-day basis, every once in a while it will jump into
first place, demanding your attention. If you work with your
medical team to monitor it on a regular basis, you will be able
to maintain greater control over the situation and manage the
interruptions that it may cause in your life. By keeping up
with a regular program of medical check-ups, you can reduce
your worry of the unknown.
The Healthy Eating Pyramid
The Healthy Eating Pyramid from the Harvard School of Public
Health (see Figure 15) is a proposed revision
of the classic Food Guide Pyramid developed by the U.S. Department
of Agriculture. It incorporates the new learning about nutrition
and cancer prevention. The Healthy Eating Pyramid sits on a
foundation of daily exercise and weight control. Why? These
two related elements strongly influence your chances of staying
healthy. They also affect what and how you eat and how your
food affects you. The other bricks of the Healthy Eating Pyramid
include:
Whole Grain Foods (at most meals). The body
needs carbohydrates mainly for energy. The best sources of carbohydrates
are whole grains such as oatmeal, whole-wheat bread, and brown
rice. They deliver the outer (bran) and inner (germ) layers
along with energy-rich starch. The body can’t digest whole
grains as quickly as it can highly processed carbohydrates such
as white flour. This keeps blood sugar and insulin levels from
rising, then falling, too quickly. Better control of blood sugar
and insulin can keep hunger at bay and may prevent the development
of type 2 diabetes.
Plant Oils. Surprised that the Healthy Eating
Pyramid puts some fats near the base, indicating they are okay
to eat? Although this recommendation seems to go against conventional
wisdom, it’s exactly in line with the evidence and with
common eating habits. The average American gets one third or
more of his or her daily calories from fats, so placing them
near the foundation of the pyramid makes sense. Note, though,
that it specifically mentions plant oils, not all types of fat.
Good sources of healthy unsaturated fats include olive, canola,
soy, corn, sunflower, peanut, and other vegetable oils, as well
as fatty fish such as salmon. These healthy fats not only improve
cholesterol levels (when eaten in place of highly processed
carbohydrates) but can also protect the heart from sudden and
potentially deadly rhythm problems.
Vegetables (in abundance) and Fruits (2 to 3 times).
A diet rich in fruits and vegetables can decrease the chances
of having a heart attack or stroke; protect against a variety
of cancers; lower blood pressure; help you avoid the painful
intestinal ailment called diverticulitis; guard against cataract
and macular degeneration; and add variety to your diet and wake
up your palate.
Fish, Poultry, and Eggs (0 to 2 times). These
are important sources of protein. A wealth of research suggests
that eating fish can reduce the risk of heart disease. Chicken
and turkey are also good sources of protein and can be low in
saturated fat. Eggs, which have long been demonized because
they contain fairly high levels of cholesterol, aren’t
as bad as they’re cracked up to be. In fact, an egg is
a much better breakfast than a doughnut cooked in an oil rich
in trans fats or a bagel made from refined flour.
Nuts and Legumes (1 to 3 times). Nuts and
legumes are excellent sources of protein, fiber, vitamins, and
minerals. Legumes include black beans, navy beans, garbanzos,
and other beans that are usually sold dried. Many kinds of nuts
contain healthy fats, and packages of some varieties (almonds,
walnuts, pecans, peanuts, hazelnuts, and pistachios) can now
even carry a label saying they’re good for your heart.
Dairy or Calcium Supplement (1 to 2 times). Building
bone and keeping it strong takes calcium, vitamin D, exercise,
and a whole lot more. Dairy products have traditionally been
the main source of calcium. But there are other healthy ways
to get calcium than from milk and cheese, which can contain
a lot of saturated fat. Three glasses of whole milk, for example,
contains as much saturated fat as 13 strips of cooked bacon.
If you enjoy dairy foods, try to stick with no-fat or low-fat
products. If you don’t like dairy products, calcium supplements
offer an easy and inexpensive way to get your daily calcium.
Red Meat and Butter (Use Sparingly): These
sit at the top of the Healthy Eating Pyramid because they contain
lots of saturated fat. If you eat red meat every day, switching
to fish or chicken several times a week can improve cholesterol
levels. So can switching from butter to olive oil.
White Rice, White Bread, Potatoes, Pasta, and Sweets
(Use Sparingly): Why are these staples at the top,
rather than the bottom, of the Healthy Eating Pyramid? They
can cause fast and furious increases in blood sugar that can
lead to weight gain, diabetes, heart disease, and other chronic
disorders. Whole-grain carbohydrates cause slower, steadier
increases in blood sugar that don’t overwhelm the body’s
ability to handle this much needed but potentially dangerous
nutrient.
Multiple Vitamin: A daily multivitamin, multimineral
supplement offers a kind of nutritional backup. While it can’t
in any way replace healthy eating, or make up for unhealthy
eating, it can fill in the nutrient holes that may sometimes
affect even the most careful eaters. You don’t need an
expensive name-brand or designer vitamin. A standard, store-brand,
RDA-level one is fine. Look for one that meets the requirements
of the USP (U.S. Pharmacopeia), or another organization that
sets standards for drugs and supplements.
Alcohol (in moderation): Scores of studies
suggest that having an alcoholic drink a day lowers the risk
of heart disease. Moderation is clearly important, since alcohol
has risks as well as benefits. For men, a good balance point
is 1 to 2 drinks a day. For women, it’s at most one drink
a day.
Pyramid and discussion adapted from Willett, Eat,
Drink, and Be Healthy, 2001
Living with Knowing
Having a chronic disease is a stressful experience. It’s
easy to say you should think of a brain tumor as a wart, but
it’s easier said than done. No one can completely avoid
stress; it’s an essential part of living. We encourage
you to incorporate into your life a stress management program
that works for you. There are many different kinds — sports,
yoga, prayer, meditation — it doesn’t matter which
one you choose as long as you do it.
Put some attention onto stress management on a regular basis.
Ask your medical team for a referral to a stress management
program, or visit your local bookstore and find a book that
you feel will be meaningful to you. Consider one by Benson,
Kabat-Zinn, Borysenko, David Burns, Albert Ellis, or another
of the many physicians who are now using stress-reduction as
a way of softening the course of chronic illness. The VHL Family
Alliance maintains a list of suggested readings on stress management
that have been found to be medically beneficial. (See Section,
Some Suggestions for Reading, below.)
Assertiveness training can help you reduce your anxiety and
improve your effectiveness in dealing with doctors and complex
situations.
A chronic disease can put strain on the best of marriages.
Don’t be shy to ask for help or counseling. You are not
alone. It is not your fault. VHL is not a punishment, it is
a disease.
Husbands, wives, parents, and children will all feel the strain
in different ways. Affected people have the very real mental
and physical pressures of the disease and its treatments and
effects. It is normal to go through denial, anger, and a whole
range of fragile emotions. It is normal to feel more needful,
and to be angry when your family doesn’t automatically
understand your needs. It is important to talk with your family
about how you are feeling. You’re not burdening them;
you are giving them the privilege of participating with you.
It is less stressful on everyone when you are partners in dealing
with VHL.
Unaffected members of the family will feel their own strains,
anger and guilt. Unaffected children may be angry that the affected
child gets all the attention, or may feel guilty that they were
spared. Affected or not, children often harbor unspoken fears
for themselves or for their parents, which may come out as misbehavior
or school performance issues. Schools often have social workers
or psychologists who can be called upon to assist children,
and in some areas there are support groups for children whose
families are affected by cancer or chronic illness.
Finding out you have VHL is a traumatic event, which quite naturally
results in normal, unpleasant reactions. It is normal to feel
anger, and it is important to work through those feelings to
a place where you can turn that negative energy into constructive
action to protect yourself and others in your family.
With patience, understanding, and the assistance of your medical
and spiritual advisers and friends, your family will survive
this challenge and thrive.
Family Support
It also helps to talk with someone who is on the same journey.
Join a family support program, such as the VHL Family Alliance.
Pick up the phone and call, if only just to talk for a while,
or join the online support group. Other families with VHL like
yours are there to listen and to share their own experiences,
which may help you gain a different perspective on the problem.
Listen and learn, or join in the conversation. Participate in
local support group meetings.
Think of it as an old-fashioned barn-raising (see Figure 17).
One person, even one couple, can’t raise a barn alone.
The community, though, can come together and do it in a few
days, pooling their skills and experiences and making the task
easier. Each member of the group benefits in turn from the community
effort.

Figure 17: “Self-help
is barn raising revisited.” —
Len Borman, founder, Illinois Self-Help Center. As quoted
in Power Tools: Ways to Build a Self-Help Group by Joal
Fischer, M.D. Art by Tina B. Farney. Booklet and art
copyright 1992 by SupportWorks, Charlotte, North Carolina.
All rights reserved. Reprinted with the kind permission
of Ms. Farney and Dr. Fischer. |
It can be frightening to reach out, but it is much worse to
be alone. Besides, we need to hear from you. It is through sharing
information that this organization was born. It is through sharing
our experiences, and putting that information together with
the expertise of the caring physicians and researchers who are
also working on VHL, that we are learning the keys to improving
diagnosis, treatment, and quality of life for everyone with
VHL.
Bringing people together
by building on personal relationships remains one of the
most effective strategies to enhance America’s social
health.
— Robert D. Putnam, Better Together |
Some Suggestions for Reading
- Robert E. Alberti, et al., Your Perfect Right: Assertiveness
and Equality in your Life and Relationships (8th edition,
2001)
- Herbert Benson, M.D., Timeless Healing: The Power and
Biology of Belief (1996)
- Joan Borysenko, Ph.D., Minding the Body, Mending the
Mind (1987)
- Jeffrey Brantley, M.D., Calming the Anxious Mind (2003)
- David Burns, Feeling Good: The New Mood Therapy
(1999)
- Albert Ellis, A Guide to Rational Living (1975)
- John A. Gottman, Ph.D. and Jean DeClaire, The Relationship
Cure (2001)
- Jerome Groopman, M.D., The Anatomy of Hope: How People
Prevail in the Face of Illness (2003)
- Jerome Groopman, Second Opinions: Stories of Intuition
and Choice in the Changing World of Medicine (2000)
- Jon Kabat-Zinn, Full Catastrophe Living: Using the Wisdom
of your Body and Mind to Face Stress, Pain, and Illness
(1990)
- Harold S. Kushner, When Bad Things Happen to Good People
(1981)
- Robert D. Putnam, Better Together: Restoring the American
Community (2003)
Questions to Ask the Doctor
With early detection and appropriate treatment, von Hippel-Lindau
disease has a better prognosis, or outcome, than many other
tumor conditions and cancers. But any diagnosis of serious illness
can be frightening, and it’s natural to have concerns
about medical tests, treatments, insurance, and doctors’
bills.
Patients have many important questions to ask about VHL, and
their medical team is the best place to start to look for answers.
Most people want to know exactly what kind of involvement they
have, how it can be treated, and how successful the treatment
is likely to be. Get a second, or even a third opinion if you
wish. The following are some questions that patients may want
to ask their physician:
- Should I change my normal activities?
- How often are checkups needed?
- What symptoms should I watch for?
- If you are told what size a tumor is (e.g. 2 cm.), ask
what that means.
- At what point do I need to worry about this tumor?
- What are the danger signals we are watching for?
- What kinds of treatment are available?
- What are the risks or side effects of treatment?
- What are the odds of those risks happening?
- What are the risks of no treatment?
- Is there a less invasive treatment I should consider?
- Can abdominal surgery be done laparoscopically?
- What other health professionals do I need on my medical
team to ensure that we have checked for all the probable features
of VHL?
- What can I do to assist doctors in learning more about
VHL?
- How experienced are you in dealing with VHL?
- Where can I consult specialists who are experienced with
VHL?
- Who will be the main person responsible for looking after
my medical interests and coordinating communication among
my specialists?
- Is there a research project I can participate in?
- Is there a clinical trial that would be appropriate for
me?
The VHL Athlete
In preparing myself for a delicate spinal
surgery, I was naturally not looking forward to the experience,
but knew that I had to get through it if I wanted to alleviate
the growing numbness and have use of my arms and hands.
I looked for a good role model. I noticed that marathon
runners, or competitors in triathalons, also push themselves
up to and beyond their physical limits. They endure pain,
thirst, and suffering, all to win the prize, to compete
sometimes more with themselves than with the others in
the race.
In addition to the careful preparation
my doctors and I went through, consulting with specialists
throughout the world to choose the best approaches for
the surgery, I trained myself for this even as if I were
training for a sports event. I made sure my body was healthy
and strong, tuned with vitamins and healthy natural foods,
and that my mind was strong as well. Through meditation
and guided imagery, I pictured the surgery going well,
the surgeons confident and successful, and my body helping
to minimize bleeding and recover quickly. I worked with
a sports trainer and used sports psychology.
The day of the surgery arrived, and our
team — my doctors and I — worked through the
day. By evening, I was awake, squeezing my husband Bruce’s
hand and wiggling my toes. Everyone cheered. We had won
the first event in the triathalon — now on to physical
therapy and back to normal life. — Jennifer
K., Australia
|
continue text |